Investors
Welcome to the Mendus investor page. Mendus is listed on NASDAQ Stockholm under the ticker symbol IMMU.
Letter from the CEO
“Focus on our lead program in AML, while creating additional upside potential in other pipeline programs”
To read the latest CEO comment, please click here.
Contact
Telephone
+46 (0)8 732 8400
info@mendus.com
Head Office
Västra Trädgårdsgatan 15
111 53 Stockholm
Sweden
R&D Offices
Emmy Noetherweg 2K
2333 BK Leiden
The Netherlands
Gothenburg Office
Mendus C/O AstraZeneca BioventureHub
Pepparedsleden 1
431 83 Mölndal
Sweden